Denis Chem Lab Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 537536 |
NSE Symbol : - |
P/E(TTM) : 21.81 |
ISIN Demat : INE051G01012 |
Div & Yield% : 1.38 |
EPS(TTM) : 8.31 |
Book Value(₹) : 59.43 |
Market Cap(₹Cr) : 251.45 |
Face Value(₹) : 10.00 |
Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|---|---|
Gross Sales | 47.82 | 41.26 | 39.85 | 40.06 | 45.43 | 42.48 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 47.82 | 41.26 | 39.85 | 40.06 | 45.43 | 42.48 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 0.58 | 0.32 | 0.59 | 0.26 | 0.52 | 0.01 |
Total Income | 48.40 | 41.58 | 40.45 | 40.32 | 45.95 | 42.49 |
Total Expenditure | 41.93 | 36.91 | 34.78 | 34.07 | 40.29 | 37.46 |
PBIDT | 6.46 | 4.67 | 5.67 | 6.25 | 5.66 | 5.04 |
Interest | 0.09 | 0.12 | 0.23 | 0.13 | 0.09 | 0.09 |
PBDT | 6.37 | 4.55 | 5.44 | 6.12 | 5.57 | 4.95 |
Depreciation | 1.66 | 1.63 | 1.75 | 1.84 | 1.76 | 1.59 |
Tax | 2.04 | 0.86 | 1.22 | 1.18 | 1.45 | 1.02 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -0.86 | -0.02 | -0.26 | -0.10 | -0.19 | -0.34 |
Reported Profit After Tax | 3.53 | 2.08 | 2.73 | 3.20 | 2.54 | 2.68 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 3.53 | 2.08 | 2.73 | 3.20 | 2.54 | 2.68 |
EPS (Unit Curr.) | 2.54 | 1.50 | 1.97 | 2.31 | 1.83 | 1.93 |
EPS (Adj) (Unit Curr.) | 2.54 | 1.50 | 1.97 | 2.31 | 1.83 | 1.93 |
Calculated EPS (Unit Curr.) | 2.54 | 1.50 | 1.97 | 2.31 | 1.83 | 1.93 |
Calculated EPS (Adj) (Unit Curr.) | 2.54 | 1.50 | 1.97 | 2.31 | 1.83 | 1.93 |
Calculated EPS (Ann.) (Unit Curr.) | 10.18 | 5.99 | 7.87 | 9.23 | 7.33 | 7.73 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 10.18 | 5.99 | 7.87 | 9.23 | 7.33 | 7.73 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 25.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 13.51 | 11.32 | 14.23 | 15.60 | 12.46 | 11.86 |
PBDTM(%) | 13.32 | 11.03 | 13.65 | 15.28 | 12.26 | 11.65 |
PATM(%) | 7.38 | 5.04 | 6.85 | 7.99 | 5.59 | 6.31 |